Poolbeg eyes transformative summer with POLB 001 data in prospect

Poolbeg Pharma: Grant of first POLB 001 cancer immunotherapy-induced CRS patent

Poolbeg Pharma plc – POLB 001 Patent Granted in United States

Poolbeg Pharma PLC Announces Directorate Change

Poolbeg Pharma
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.